AKT1 and metabolic dysfunction-associated steatotic liver disease: Moreover, compared with those in control subjects, the protein expression levels of hepatic ENO3 and p-Akt (Ser473) proteins in patients with NAFLD were significantly reduced, and the protein level of hepatic p-IRS2 (Ser1100) was markedly increased (Figure 7e,f).